Gene · 963
Papers1,502
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,502
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular signals regulate the biogenesis of extracellular vesicles. | Biol Res | 2022 | 36435789 | PubTator, text mining | PubMed |
| Genes related to allergen exposure in allergic rhinitis: a gene-chip-based study in a mouse model. | BMC Med Genomics | 2022 | 36434595 | PubTator, text mining | PubMed |
| Identification of Factors Driving Doxorubicin-Resistant Ewing Tumor Cells to Survival. | Cancers (Basel) | 2022 | 36428591 | PubTator, text mining | PubMed |
| CD6-mediated inhibition of T cell activation via modulation of Ras. | Cell Commun Signal | 2022 | 36414966 | PubTator, text mining | PubMed |
| Identification and validation of a novel phagocytosis regulators-related signature with potential prognostic and immunotherapeutic value in patients with lung adenocarcinoma. | Front Oncol | 2022 | 36408131 | PubTator, text mining | PubMed |
| Leukocyte metabolism in obese type 2 diabetic individuals associated with COVID-19 severity. | Front Microbiol | 2022 | 36406408 | PubTator, text mining | PubMed |
| Defining the characteristics of interferon-alpha-stimulated human genes: insight from expression data and machine learning. | Gigascience | 2022 | 36399061 | PubTator, text mining | PubMed |
| Potential impact of WTAP and YTHDF2 on tumor immunity in lung adenocarcinoma. | Medicine (Baltimore) | 2022 | 36397411 | PubTator, text mining | PubMed |
| Blood biomarkers to predict the onset of pre-eclampsia: A systematic review and meta-analysis. | Heliyon | 2022 | 36387521 | PubTator, text mining | PubMed |
| Identification of Ribonuclease 6 as an immunoinflammatory key gene associated with the glomerular injury in diabetic nephropathy. | Sci Rep | 2022 | 36385487 | PubTator, text mining | PubMed |
| Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library. | Genome Med | 2022 | 36380343 | PubTator, text mining | PubMed |
| Single-cell analysis of multiple myelomas refines the molecular features of bortezomib treatment responsiveness. | Exp Mol Med | 2022 | 36380017 | PubTator, text mining | PubMed |
| Blockade of the immunosuppressive KIR2DL5/PVR pathway elicits potent human NK cell-mediated antitumor immunity. | J Clin Invest | 2022 | 36377656 | PubTator, text mining | PubMed |
| Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinoma. | PLoS One | 2022 | 36367894 | PubTator, text mining | PubMed |
| Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors. | Int J Mol Sci | 2022 | 36362398 | PubTator, text mining | PubMed |
| HPV-Related Cervical Cancer and Extracellular Vesicles. | Diagnostics (Basel) | 2022 | 36359429 | PubTator, text mining | PubMed |
| Multi-spectral immunofluorescence evaluation of the myeloid, T cell, and natural killer cell tumor immune microenvironment in chordoma may guide immunotherapeutic strategies. | Front Oncol | 2022 | 36338744 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| An OX40L mRNA vaccine inhibits the growth of hepatocellular carcinoma. | Front Oncol | 2022 | 36313716 | PubTator, text mining | PubMed |
| Unraveling the surface proteomic profile of multiple myeloma to reveal new immunotherapeutic targets and markers of drug resistance. | Cell Stress | 2022 | 36311892 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/963/papers?page=13